Description of Blood Analysis: 

Glycoprotein antigen CA-125 is a complex molecular compound produced by the cells of the serous membranes lining the internal cavities and pelvic organs. In a healthy state, this component exists in the blood only in trace amounts. An increase in its concentration serves as a biochemical indicator of tissue changes, occurring when the balance between natural cell renewal and breakdown is disrupted. In clinical practice, CA-125 acts as a significant marker of biological stability, allowing specialists to track the progress of conditions in response to internal and external factors.

What does the analysis represent?

• Purpose: Precise quantitative measurement of CA-125 marker content in blood serum.
• Primary Application: Long-term monitoring of pelvic organs and the peritoneum, evaluating treatment results, and analyzing biological trends.
• Method: Laboratory diagnosis of venous blood using modern immunochemical methods.

Recommendations for the Test (General)

• Timing: Blood collection is preferably done in the morning.
• Fasting: A fasting period of 4–6 hours is recommended.
• Rest: It is important to sit calmly for at least 15–20 minutes before the procedure.
• Cycle details: Physiological increases often occur during menstruation; thus, test timing should be coordinated with a gynecologist.

What can affect the results?

• Factors increasing levels: Endometriosis, ovarian cysts, pelvic inflammatory diseases, pregnancy, and recent abdominal surgeries.

When to take the test?

• Recommendations: Ordered by a specialist to control identified changes or as part of a comprehensive preventative check-up.
• Preparation: Best performed outside of acute inflammatory phases unless otherwise specified by a physician.

How to interpret the results?  

Data interpretation is a professional task for the physician. The CA-125 value is never used as the sole basis for a diagnosis. The specialist assesses the result relative to patient complaints, the menstrual cycle phase, and Ultrasound or MRI data. Self-interpretation of the numbers is unacceptable, as elevations may stem from benign causes that only an expert can clinically evaluate.

Possible further investigations

• Ultrasound: The primary visualization method for pelvic and abdominal organs.
• Additional Markers: Combined determination with HE4 antigen (ROMA index calculation).
• Visualization: Pelvic MRI or CT to clarify the nature and location of identified changes.

When does the next step make sense?

If the CA-125 analysis is used for pelvic organ monitoring, the results are reviewed by a doctor alongside the cycle phase and examination data. Observation tactics or additional tests are decided individually following a professional medical assessment. 

👉 If necessary, you can discuss the analysis results with a specialist such as a gynecologist ( Doctors – TAMC ).